Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: YONGAN PHARMACEUTICAL(002365) the Revenue is 327.81 M (+67.06%);the EBIT is 55.2 M (+792.9%);the EPS is 0.123 (+111.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.33B67.06%
----
----
EBIT
0.06B792.93%
----
----
EPS
0.1231111.59%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf